Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab

Neoadjuvant chemotherapy (NAC) for breast cancer is widely employed and we performed genome-wide association studies (GWAS) to determine if germline genetic variability was associated with benefit in terms of pathological complete response (pCR), disease-free survival (DFS), and overall survival (OS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacogenet Genomics
Main Authors: Ingle, James N., Kalari, Krishna R., Wickerham, D. Lawrence, von Minckwitz, Gunter, Fasching, Peter A., Furukawa, Yoichi, Mushiroda, Taisei, Goetz, Matthew P., Barman, Poulami, Carlson, Erin E., Rastogi, Priya, Costantino, Joseph P., Cairns, Junmei, Paik, Soonmyung, Bear, Harry D., Kubo, Michiaki, Wang, Liewei, Wolmark, Norman, Weinshilboum, Richard M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5965682/
https://ncbi.nlm.nih.gov/pubmed/29768301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados